rebel Financial rebel Financial
← All Posts
INDV

Indivior Pharmaceuticals, Inc.

October 16, 2026 • Author: Phil Ratcliff • INDV
Item Proposal Vote
1 To approve the issuance of shares of common stock, par value $0.001 per share, of Indivior Pharmaceuticals, Inc. ("Indivior") in connection with the merger as contemplated by the Agreement and Plan of Merger, dated as of August 1, 2026, by and among Indivior, Artemis Merger Sub Inc. and Supernus Pharmaceuticals, Inc., including for purposes of complying with the applicable provisions of Nasdaq Rule 5635 (the "Indivior Share Issuance Proposal"). ✓ For
2 To approve one or more adjournments of the special meeting to a later date or time, if necessary or appropriate, including adjournments to permit the solicitation of additional votes or proxies in favor of the Indivior Share Issuance Proposal if there are insufficient votes at the time of such adjournment to approve such proposal. ✓ For
Attachments
📄
INDV_Proxy_Statement_10122026.pdf 1.6 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.